loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Germany-Hamburg: Pharmaceutical products

World Biggest Tenders Source

This tender with title Germany-Hamburg: Pharmaceutical products has been published on Bidding Source portal dated 27 Jan 2019 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Germany-Hamburg: Pharmaceutical products
Contract notice
2019/S 017-035386
Germany
Germany-Hamburg
27 Jan 2019
5 Jan 2021
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Germany - Conclusion of non-exclusive discount agreements in accordance with; §§ 130a Para. 8/130c Para. 1 SGB V on medicinal products with the active ingredient certolizumab pegol (L04AB05) as part of an open house model. - Pharmaceutical products Germany Germany - Conclusion of non-exclusive discount agreements in accordance with; §§ 130a paragraph 8/130c paragraph 1 SGB V on drugs with the active ingredient urapidil (C02CA06) as part of a so-called open house model. - Pharmaceutical products Germany Germany - Open House Rabattverträge 2023-04 - Pharmaceutical products Germany Germany - Conclusion of non-exclusive drug discount agreements according to § 130a Para. 8 SGB V by means of a so-called open-house model for the active substance fulvestrant (ATC code according to WHO: L02BA03) - Pharmaceutical products Germany Germany - Conclusion of non-exclusive drug discount agreements according to § 130a Para. 8 SGB V by means of a so-called open-house model for the active ingredient tamsulosin/dutasteride (ATC code WHO: G04CA52) - Pharmaceutical products Germany Germany - Conclusion of non-exclusive discount agreements in accordance with; §§ 130a paragraph 8/130c paragraph 1 SGB V on drugs with the active ingredient tofacitinib (L04AA29) as part of a so-called open house model. - Pharmaceutical products Germany Germany - Conclusion of non-exclusive drug discount agreements according to § 130a Para. 8 SGB V by means of a so-called open-house model for the active ingredient cinacalcet (ATC code WHO: H05BX01) - Pharmaceutical products Germany Germany - Open House Biologika Discount contract 2023-02 - Follitropin beta - Pharmaceutical products Germany Germany - Conclusion of non-exclusive discount agreements in accordance with; §§ 130a paragraph 8/130c paragraph 1 SGB V on drugs with the active ingredient formoterol and aclidinium bromide (R03AL05) as part of an open house model. - Pharmaceutical products Germany Germany - 2023-03-mallersdorf-pharmacy services - Pharmaceutical products Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans